Position in ADAG
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$33,436
-$225,863 QoQ
Shares Held
7,961
-88.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 36 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ADAG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. ADAG ranks #381 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ADAG
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,436 | 7,961 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $259,299 | 66,148 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $142,969 | 75,645 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $164,676 | 82,752 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $150,614 | 77,238 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $150,591 | 99,074 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $201,399 | 101,206 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $213,277 | 96,071 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $287,409 | 93,894 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $239,895 | 85,677 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $283,318 | 146,721 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $160,982 | 105,217 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $81,796 | 55,268 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,325 | 9,190 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,527 | 7,945 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,617,709 | 1,263,836 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,949,268 | 2,395,580 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $4,852,655 | 1,386,473 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $11,179,657 | 1,385,679 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $19,888,025 | 1,384,478 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,177,567 | 1,414,275 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $8,167,536 | 455,016 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||